Next-Generation Biomanufacturing Market Size to Surpass US$ 34.81 billion by 2031 – Growth Plus Reports

Pune, Dec. 18, 2023 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Next-Generation Biomanufacturing Market is expected to clock US$ 34.81 billion by 2031 and to grow at a CAGR of 6.9% during the forecast period.

In a pivotal moment for the biopharmaceutical industry, the Next-Generation Biomanufacturing Market emerges as a catalyst for innovation, ushering in a new era of production efficiency, scalability, and sustainability. This press release explores the transformative impact of next-generation biomanufacturing technologies, highlighting their crucial role in advancing biopharmaceutical production and meeting the demands of a dynamic and evolving market.

Get a Sample Copy of the Research Report:

                                    Next-Generation Biomanufacturing Market Scope

Report Attribute Details
Market Size Value in 2022 US$ 19.02 billion
Revenue Forecast in 2031 US$ 34.81 billion
CAGR 6.9%
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Workflow Type, Application, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market Overview:

The Next-Generation Biomanufacturing Market represents a paradigm shift in biopharmaceutical production methodologies. Leveraging cutting-edge technologies, these advancements address challenges associated with traditional biomanufacturing processes, offering solutions for enhanced productivity, flexibility, and cost-effectiveness.

Key Drivers of Growth:

  1. Increasing Demand for Biopharmaceuticals:
    • The growing demand for biopharmaceuticals, including monoclonal antibodies and recombinant proteins, necessitates more efficient and scalable manufacturing processes. Next-generation biomanufacturing technologies respond to this demand with streamlined and advanced production methods.
  2. Technological Advancements in Bioprocessing:
    • Continuous innovations in bioprocessing technologies, such as single-use systems, continuous manufacturing, and process analytical technology (PAT), contribute to the development of more robust and agile biomanufacturing processes.
  3. Biological and Biosynthetic Advancements:
    • Advances in genetic engineering, cell culture technologies, and synthetic biology play a pivotal role in optimizing cell lines and production strains. These biological enhancements improve product yields, quality, and overall process efficiency.
  4. Focus on Sustainability and Environmental Impact:
    • Next-generation biomanufacturing emphasizes sustainability by incorporating eco-friendly practices, reducing resource consumption, and minimizing waste generation. This aligns with the broader industry trend towards environmentally conscious production processes.
  5. Flexible and Modular Manufacturing Approaches:
    • The need for adaptable and scalable manufacturing approaches drives the adoption of flexible and modular systems. Next-generation biomanufacturing facilitates the efficient production of multiple products with varying production scales.

Diverse Range of Next-Generation Biomanufacturing Technologies:

  1. Single-Use Bioprocessing Systems:
    • Single-use technologies eliminate the need for cleaning and validation, providing a more agile and cost-effective approach to biopharmaceutical production. These systems offer flexibility in scale and reduce the risk of cross-contamination.
  2. Continuous Manufacturing Platforms:
    • Continuous manufacturing processes allow for uninterrupted production, offering advantages in terms of efficiency, quality control, and real-time monitoring. This approach contrasts with traditional batch processing, enabling a more streamlined and continuous supply chain.
  3. Automation and Robotics Integration:
    • The integration of automation and robotics enhances precision and efficiency in biomanufacturing. Automated systems contribute to error reduction, increased throughput, and consistent product quality.
  4. Advanced Downstream Processing Techniques:
    • Innovations in downstream processing, including novel purification methods and chromatography technologies, improve the efficiency of isolating and purifying biopharmaceutical products.

Challenges and Opportunities:

  1. Regulatory Compliance and Standardization:
    • Ensuring compliance with evolving regulatory standards and achieving industry-wide standardization present challenges. Opportunities lie in collaborative efforts among industry stakeholders to establish and adopt standardized practices.
  2. Technology Transfer and Training:
    • The adoption of next-generation biomanufacturing technologies requires effective technology transfer and workforce training. Opportunities exist for knowledge-sharing initiatives and comprehensive training programs to support industry-wide proficiency.

Global Market Landscape:

Major players in the Next-Generation Biomanufacturing Market include GE Healthcare, Merck KGaA, Thermo Fisher Scientific, and Sartorius AG. These companies contribute to market growth through research and development initiatives, strategic collaborations, and the introduction of innovative biomanufacturing solutions.

Future Outlook:

As the Next-Generation Biomanufacturing Market continues to evolve, future developments are anticipated in areas such as artificial intelligence-driven bioprocess optimization, personalized medicine manufacturing, and the integration of sustainability metrics into biopharmaceutical production. The market is poised to play a central role in shaping the future of biomanufacturing on a global scale.

Request for Customization –

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Upstream Biomanufacturing Workflow
    2. Single-Use Upstream Biomanufacturing Workflow
    3. Downstream Biomanufacturing Workflow
    1. Monoclonal Antibodies
    2. Vaccines
    3. Recombinant protein
    4. Hormones
    5. Others
    1. Biopharmaceutical Companies
    2. Research Institutions
    3. Contract Research Organizations

Browse full TOC here.


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Buy this Premium Research Report:


The Next-Generation Biomanufacturing Market stands at the forefront of transforming how biopharmaceuticals are produced, offering a glimpse into a future characterized by efficiency, flexibility, and sustainability. By embracing next-generation technologies, the biopharmaceutical industry paves the way for a more agile and responsive approach to meeting the healthcare needs of a rapidly evolving world.

Browse other reports:

Expression Vectors Market
Genetic Testing Services Market
Ureteroscopes Market
Surgical Tables Market
Temperature Monitoring Systems Market
Microfluidics Market
Microbial Fermentation Technology Market
Cell Expansion Market
Human Microbiome Market
Western Blotting Market

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: Phone no: +1 888 550 5009 Web:  Follow Us: LinkedIn | Twitter  

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy